Find the Perfect Plan for Your Investment Journey
M
Latest price
52 Week Range
€12.00 - €19.00
Next Earnings Date
Jun 17 2025 (Estimate)
Next Earnings Date
Jun 17 2025 (Est.)
Latest price
Market Cap | €494.28M |
EV | €524.63M |
Shares Outstanding | 33.32M |
Beta | 1.27 |
Analyst Rating | BUY |
Analyst Target Price | €22.40 |
P/E 2025E | - |
P/Revenue 2025E | 24.14x |
Revenue | 3.30% |
EPS | -0.80% |
Operating Cash Flow | 0.60% |
Free Cash Flow | -32.50% |
Revenue | 108.40% |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2025E | 100.00% |
Net Profit Margin 2025E | -79.91% |
ROE 2025E | 110.60% |
ROCE 2024 | - |
DPS 2025E | €0.00 |
Payout Ratio 2025E | 0.00% |
Div. Yield 2025E | 0.00% |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
M
MedinCell S.A.
MEDCL
Sector
Healthcare
Industry
Biotechnology
CEO
Douat, Christophe
Employees
131
Website
www.medincell.comIPO Date
2018-10-08
Headquarters
3 rue des FrEres LumiEre, Jacou, Languedoc-Roussillon, 34830, France
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved